Consider this composite case. A 32-year-old woman with no family history of cancer presents with rectal bleeding and abdominal discomfort, and a colonoscopy finds a stage III tumour in the sigmoid colon. Her case is statistically no longer unusual. Between 1990 and 2019, the global incidence of cancer in people aged 14 to 49 rose by 79 per cent, according to a 2023 Global Burden of Disease analysis covering 29 cancer types and 204 countries, published in BMJ Oncology by Zhao and colleagues [1]. Cancer deaths in this age group climbed by almost 28 per cent, reaching 1.06 million in 2019, and researchers have projected a further 31 per cent rise in incidence and 21 per cent rise in deaths by 2030, with people in their 40s most exposed [1].
The figures have unsettled oncologists trained to think of cancer as a disease of ageing, and shifted the attention of epidemiologists toward a third idea: that something about the way people born after 1950 grew up is rewiring their cancer risk, generation by generation.
The birth cohort effect
The cleanest evidence for that idea comes from a 2024 Sung et al. study in The Lancet Public Health, which tracked more than 23.6 million US cancer patients and 7.3 million deaths between 2000 and 2019 [2]. In 17 of 34 cancer types, incidence rates rose with each successively younger birth cohort, including breast, pancreatic, and gastric cancers. For pancreatic, kidney, and small intestinal cancers, the rate in people born in 1990 was two to three times higher than in those born in 1955; uterine corpus cancer was 169 per cent higher in the 1990 cohort than in the lowest-incidence birth cohort identified [2].
"We have identified cancer trends associated with birth years, but we don't yet have a clear explanation for why these rates are rising," said lead author Dr Hyuna Sung [2]. The pattern is what epidemiologists call a birth cohort effect. Rebecca Siegel, the American Cancer Society epidemiologist, put it more sharply in 2026: "It's an example of the 'birth cohort effect.' People born after the 1950s face heightened risk... it's increasing the risk more and more with every subsequent generation" [4]. Dr Ahmedin Jemal, senior vice president at ACS, warned that without effective interventions, the elevated risk in younger generations could halt or reverse decades of progress [2].
Australia is the clearest case study. Bowel cancer rates among people born in the 1990s are two to three times higher than among those born in the 1950s, and the risk of diagnosis before age 40 has more than doubled since 2000, according to Bowel Cancer Australia's 2024 review [3]. Australia has recorded a 266 per cent increase in bowel cancer incidence in adolescents and young adults aged 15 to 24 over the past three decades [3]. Across Australia, Canada, England, and the United States, the per-annum rise in early-onset bowel cancer has been 3.7 per cent among 20- to 49-year-olds, and 7 per cent in 20- to 39-year-olds [3].
Colorectal cancer: the bellwether
If there is a flagship disease for the early-onset surge, it is colorectal cancer. In the United States, it is now the leading cause of cancer death in men and women under 50, having risen from the fifth leading cause in the 1990s, according to the American Cancer Society's 2026 mortality analysis published in CA: A Cancer Journal for Clinicians and reported by The Guardian [4][5]. Despite a 44 per cent decline in US cancer mortality under 50 since 1990, colorectal cancer is the only one of the five leading under-50 cancers in which deaths continue to climb [4].
The clinical toll is compounded by late diagnosis. About three-quarters of under-50 colorectal cancer patients in the US have stage III or IV disease at presentation, often because they fall below the traditional screening age or have had symptoms dismissed as "too young" [4]. The Colorectal Cancer Alliance estimates a young American is diagnosed every 25 minutes, and projects a 90 per cent rise in incidence among 20- to 39-year-olds by 2030 [6].
Australia mirrors the trend with a sharper edge: it has the highest documented rate of early-onset bowel cancer among 50 countries surveyed, with one in eight patients (12.6 per cent) diagnosed under 50 and more than 1,800 young Australians per year [3]. Bowel cancer is now the deadliest cancer in Australians aged 25 to 54 [3]. The UK carries a comparable overall burden, with 48,213 new cases and 17,700 deaths a year, 10-year survival at 53.9 per cent, and an estimated 54 per cent of cases deemed preventable, according to Cancer Research UK [7]. Cancer Research UK's published statistics do not separate out under-50 mortality, so a direct UK ranking for that age group is harder to pin down than the US or Australian figures.
What researchers are circling
The honest summary, from a 2023 BMJ Oncology editorial by researchers at Queen's University Belfast, is that "full understanding of the reasons driving the observed trends remains elusive" [1]. What follows is a list of plausible, partially supported, and largely unproven suspects.
Diet is the most consistent lead. The Zhao et al. analysis identified diets high in red meat and salt, and low in fruit and milk, as the main dietary risk factors for the most common early-onset cancers [1]. The BMJ Group's summary of the paper also flagged alcohol and tobacco as main risk factors, with physical inactivity, excess weight, and high blood sugar as contributory factors [9]. The American Cancer Society has pointed to increased consumption of ultra-processed foods, processed meats, and foods packaged in plastic as plausible, though unproven, contributors to the young-onset colorectal rise [5]. In Australia, the Cancer Council lists low fibre, high red and processed meat intake, being overweight or obese, alcohol, and smoking as the established modifiable risks for bowel cancer, even if they do not fully account for the steepness of the early-onset curve [8].
Obesity and inactivity are contributory, but not the whole story. New cases of early-onset windpipe (nasopharynx) and prostate cancer rose fastest between 1990 and 2019, with estimated annual percentage changes of 2.28 per cent and 2.23 per cent respectively, a pattern the authors note is not wholly explained by obesity and metabolic risk factors [1]. The microbiome is the second active front: researchers are investigating antibiotic overuse in childhood, disruptions to gut bacteria, and early-life exposures [1]. Siegel told The Guardian that microplastics are provably capable of crossing the blood-brain barrier, "so the colon is clearly being exposed," a hypothesis rather than a confirmed cause [5]. Outdoor air pollution has also been flagged [1].
In Australia, where 75-84 per cent of early-onset bowel cancers are sporadic, Bowel Cancer Australia describes the picture as "a convergence of lifestyle exposures, birth cohort effect in people born after 1950 and interrelated factors such as diet, bacteria in the gut, and inflammation" [3].
What we still don't know
The most important thing to say about the early-onset surge is what the data cannot yet tell us. No single cause has been definitively established, and the variable quality of cancer registry data in many low- and middle-income countries may be obscuring the true size of the increase [10]. Genetics is not the answer at the population level: although hereditary syndromes, principally Lynch syndrome, account for 16-25 per cent of early-onset bowel cancers, the rapid generational shift in incidence cannot be explained by inherited mutations, which do not change that quickly [3].
There is no consensus yet on how best to manage the new cohort of younger patients. Young patients in Australia were until recently managed under clinical guidelines that were not age-specific, even though early-onset disease more often presents in the rectum and at a more advanced stage than late-onset disease [11]. A 2024 international analysis of 23.9 million patients under 50 identified blood in the stool, abdominal pain, altered bowel habits, and unexplained weight loss as the most common presenting signs [11].
The practical implications are already visible. Screening programmes are being expanded to younger adults, the Colorectal Cancer Alliance has launched Project Cure CRC, and clinicians are being urged to take these symptoms seriously in patients well below the historical "cancer age" [6][11]. In Australia, where the early-onset rate is the world's highest, the policy conversation has moved from "is this real?" to "what do we do for a generation that is statistically sicker than its parents were at the same age?"
Researchers do not yet have a complete answer. The next decade of research will determine whether the early-onset surge is a generational anomaly, the leading edge of a longer rise, or both. For now, the most accurate summary is also the most uncomfortable one: a generation has begun to get cancer earlier, in larger numbers, and from causes that the best laboratories in the world cannot yet fully explain.
This article was drafted with AI assistance. The opening case is an illustrative composite, not a real patient.